Website profile

@Oncodaily

OncoDaily is a specialized oncology news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments in the f

  • 825articles · 30d
  • 3+ hour agolatest article
  • Aug 14, 2026earliest in window
  • 10%with images · 19 videos
  • 188avg words
articles per day
Categories
  • Health & Wellness 797
  • Medical 763
  • Health 754
  • Education & Jobs 40
  • Human Interest 25
  • Science & Technology 19
  • Education 15
  • Business & Industrial 6

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
oncodaily.com > voices > cosimo-commisso-pancreatic-cancer-585561

Cosimo Commisso: Pancreatic Cancer Builds Immune Safe Zones to Evade Treatment

6+ hour, 59+ min ago   (197+ words) / Alessia Baccarini, Alexander Tepper, Bhavya Singh, Brian D. Brownsvg, cancer,, Alessia Baccarini, Alexander Tepper, Bhavya Singh, Brian D. Brownsvg, cancer, Chiara Falcomatà, Cosimo Commisso, Divya Chhamalwan, Gurkan Mollaoglu, Hunter T. Potak, Icahn School of Medicine at Mount Sinai, Matthew D. Park, Maxime…...

Oncodaily - Oncology News
oncodaily.com > voices > sahar-mansour-breast-cancer-585403

Sahar Mansour: AI’s Role in Detecting Subtle Breast Cancer Changes - OncoDaily

9+ hour, 6+ min ago   (293+ words) Sahar Mansour, Professor of Radiology at Kasr Al-Ainy Hospital, Cairo University, shared on LinkedIn: “When “Stable for 10 Years” May Not Be Enough Recently at Baheya Foundation, we encountered a breast cancer case that highlights the value of AI-assisted screening. In…...

Google News
oncodaily.com > event > cytoreductive-surgery-584057

ESSO Video-Based Workshop on Cytoreductive Surgery - Oncology News, Insights, Stories by OncoDaily

3+ day, 4+ hour ago   (127+ words) Discussions Around the DeLLphi-305 Trial FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer Benjamin L. Ebert: A Major Step Forward for Personalized Cancer Vaccines Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for…...

Oncodaily - Oncology News
oncodaily.com > event > esso-584054

ESSO Webinar: Radar-Guided Precision Localisation in Melanoma and Sarcoma - Oncology News, Insights, Stories by OncoDaily

3+ day, 4+ hour ago   (130+ words) Discussions Around the DeLLphi-305 Trial FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer Hodgkin Lymphoma in 2026: What the New EHA Guidelines Recommend Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for Health…...

Oncodaily - Oncology News
oncodaily.com > voices > simmons-cancer-center-583971

Congratulations to Simmons Cancer Center Members Receiving UT Southwestern Medical Center Leaders in Clinical Excellence Awards! - OncoDaily

3+ day, 7+ hour ago   (64+ words) Congratulations to Simmons Cancer Center Members Receiving UT Southwestern Medical Center Leaders in Clinical Excellence Awards! oncodaily.com Congratulations to Simmons Cancer Center Members Receiving UT Southwestern Medical Center Leaders in Clinical Excellence Awards! UTSW Simmons Cancer Center shared on…...

Oncodaily - Oncology News
oncodaily.com > industry > botbal-583928

BOT+BAL: Three-Year Overall Survival Data in Recurrent Ovarian Cancer - Agenus - OncoDaily

3+ day, 7+ hour ago   (116+ words) BOT+BAL: Three-Year Overall Survival Data in Recurrent Ovarian Cancer - Agenus / Agenus, Balstilimab, BOTBAL, botensilimab, C-800-01, cancer, OncoDaily,, Agenus, Balstilimab, BOTBAL, botensilimab, C-800-01, cancer, OncoDaily, Oncology, Ovarian Cancer, overall survival, Phase 1b, Phase 1b Clinical Trial, Recurrent ovarian cancer Agenus, shared on LinkedIn: “Agenus…...

Oncodaily - Oncology News
oncodaily.com > voices > jigjidsuren-chinburen-583857

Jigjidsuren Chinburen: Robotic Surgery is Entering Mongolian Hospitals - OncoDaily

3+ day, 8+ hour ago   (187+ words) While robotic surgery, one of the world’s advanced medical technologies, once seemed far away, today it has actually entered Mongolian hospitals and is expanding its reach. In December 2025, the National Cancer Center first introduced robotic surgery, making Mongolia the 70th country…...

Oncodaily - Oncology News
oncodaily.com > voices > duke-university-school-of-medicine-583217

David Tuveson Will Join Duke Cancer Institute as Executive Director - Duke University School of Medicine - OncoDaily

3+ day, 18+ hour ago   (109+ words) David Tuveson Will Join Duke Cancer Institute as Executive Director - Duke University School of Medicine Oncodaily David Tuveson Will Join Duke Cancer Institute as Executive Director – Duke University School of Medicine Duke University School of Medicine shared on LinkedIn: “David…...

Google News
oncodaily.com > societies > international-cardio-oncology-society-583571

It's Vascular Nurses Week! - International Cardio-Oncology Society

4+ day, 3+ hour ago   (52+ words) It’s Vascular Nurses Week! – International Cardio-Oncology Society Oncodaily It’s Vascular Nurses Week! – International Cardio-Oncology Society International Cardio-Oncology Society (IC-OS) shared on X: “It’s Vascular Nurses Week! In cardio oncology, vascular nurses are on the front lines – managing access lines, watching…...

Oncodaily - Oncology News
oncodaily.com > voices > michael-oberreiter-583093

Michael Oberreiter: From Health Economics to the Economics of Health - OncoDaily

4+ day, 13+ hour ago   (295+ words) Michael Oberreiter, Head of External Affairs International at Roche, shared on LinkedIn: “Sunday afternoons are a good time to let my brain wander off. Next destination: is it time to move from health economics to the economics of health? I’ve…...